Market Overview

UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on TearLab Corporation

Related TEAR
Morning Market Losers
UPDATE: TearLab Posts Q4 Loss

In a report published Monday, Canaccord Genuity reiterated its Buy rating on TearLab Corporation (NASDAQ: TEAR), and raised its price target from $6.00 to $8.00.

Canaccord Genuity noted, “Given strong underlying business trends, we increase our price target to $8 from $6 as we believe the growth profile of the stock justifies a higher multiple. In our opinion, TEAR should start benefitting from physician referrals (>500 IB), expanding sales force (12 reps and four managers), and robust lead activity from AAO conference.”

TearLab Corporation closed on Friday at $5.31.

Latest Ratings for TEAR

Nov 2014Feltl & Co.UpgradesBuyStrong Buy
Nov 2014Canaccord GenuityMaintainsBuy
Aug 2014Feltl & Co.DowngradesStrong BuyBuy

View More Analyst Ratings for TEAR
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Price Target Analyst Ratings


Related Articles (TEAR)

View Comments and Join the Discussion!

Get Benzinga's Newsletters